Kinedrongen SRL
Kinedrongen reported total assets of 124,332 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Aug 2026).
By total assets for 2025, Kinedrongen ranks in the top half of the 5,000 companies in its sector (NACE 8695) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Kinedrongen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Kinedrongen's annual accounts
| 2025 | |
|---|---|
| Net result | 95,161 € |
| Equity | 99,161 € |
| Cash | 28,974 € |
| EBITDA | 149,848 € |
| Total assets | 124,332 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Aug 2026
Kinedrongen's financial analysis
- Solvency79.8%sector median: 61.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Kinedrongen
Kinedrongen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1014.981.373
- VAT number
- BE1014981373
- Peppol
- Registered · 0208:1014981373 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Oct 2024
- Registered office
- 9031 Ghent
- Latest accounts
- 2025 · filed on 13 Aug 2026
- Activity
- Physical therapy activities (NACE 86951)
Kinedrongen (SRL) has been based in Ghent since 2024, active in: physical therapy activities. For 2025, it reports a net profit of 95,161 € and equity of 99,161 €; its revenue is not published. Its solvency stands at 79.8%, above the median of its sector (61.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Kinedrongen
Companies in the same business, of comparable size and area, outside its group.
- Kinesud Physiotherapy activities Virton · balance sheet 138,260 €
- Bart de Wilde - Manuele Therapie Physiotherapy activities Wetteren · balance sheet 125,741 €
- Kinesitherapie Ellen Van der Veken Physiotherapy activities Heist-op-den-Berg · balance sheet 122,588 €
- Kinecoach VH Physiotherapy activities Puurs-Sint-Amands · balance sheet 121,930 €
- Kine Jana Vanhove Physiotherapy activities Lichtervelde · balance sheet 128,073 €
- Kinépraktijk Vander Stricht Physiotherapy activities Laarne · balance sheet 128,664 €
- Louvyst Physiotherapy activities Fontaine-l'Évêque · balance sheet 119,767 €
- Quintelier Yannick Physiotherapy activities Brecht · balance sheet 118,397 €
Frequently asked questions about Kinedrongen
What is the revenue of Kinedrongen?
Kinedrongen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Kinedrongen?
In Belgium, the VAT number is the company number prefixed with BE: BE1014981373 for Kinedrongen, if the company is VAT-registered. Its company number (CBE) is 1014.981.373.
Where is the registered office of Kinedrongen?
According to the CBE register, the registered office of Kinedrongen is in 9031 Ghent.
What is the equity of Kinedrongen?
At the close of the 2025 financial year, the equity of Kinedrongen amounts to 99,161 €, a solvency of 79.8% of total assets.
Who manages Kinedrongen?
The register lists 1 active mandates at Kinedrongen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Kinedrongen within its sector?
By total assets for 2025, Kinedrongen ranks in the top half of the 5,000 companies in its sector (NACE 8695) in Belgium that filed accounts for that financial year.
The full file of Kinedrongen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →